22 Mar 2022 Orthocell Media, Video 22 March 2022 Orthocell Orthocell Managing Director, Paul Anderson, spoke with Andrew Scott from Proactive Investors to discuss Australian regulatory (TGA) approval for our Remplir™ nerve repair device.
